Abstract:Objectives: α-thalassemia is an autosomal recessive monogenic blood disorder, affecting up to 5% of the world's population. The occurrence rate of the disease in Vietnam varies up to up to 51.5%, with high rate of mutation carriers, of couples consisting of two carriers at risk of bearing a child with fetal Hb Bart, which can develop into hydrops fetalis syndrome, threatening the well-being of the mother and the child. Our study aims to facilitate birth of healthy/asymptomatic children of α-thalassemia carrier couples who received reproductive service at our centre during the period of 2019-2022. Materials and methods: 89 couples at risks of having α-thalassemia offsprings requested IVF procedures and PGD at Post Hospital during 2019-2022 were recruited for investigation. Couple and additional family members' peripheral blood samples of couples and additional family members were subjected to haemoglobin electrophoresis, DNA extraction for α-thalassemia gene mutation detection and STRs linkage analysis. Data were observed and analysed on GeneMarker software. Results: 91 cycles of PGD for α-thalassemia were carried out for 89 couples. α-thalassemia large deletion (--SEA/αα) was the most common mutation identified in 88 couples, in which 4 cases also carried β-thalassemia point mutations. Combining results of PGS and PGD, 278/424 amplified embryos were transferable (HBA-mutation free or carriers of single heterozygous HBA mutation, without chromosomal abnormality). 64/89 couples have been transferred with the embryos (prioritizing mutation free ones over carriers), resulting in the birth of 36 α-thalassemia disease-free children, 17 ongoing pregnancies, and 11 with miscarriages. Conclusion: Successful application of microsatellite-based method in PGD facilitated the birth of 36 healthy children and 17 ongoing pregnancies for 53/64 couples with embryo-transferred. All resulted clinical births displayed confirmation results in line with the PGD results, thus demonstrating the feasibility and credibility of the use of STR markers in PGD.

Application of Real-Time Fluorogenic PCR in the Diagnosis of Beta-Thalassemia Before Embryo Implantation

Preimplantation Genetic Diagnosis of Human Embryos with Α-Thalassemia

Application of short tandem repeats (STRs) in the preimplantation genetic diagnosis (PGD) of α-thalassemia

Medium-based Noninvasive Preimplantation Genetic Diagnosis for Human Α-Thalassemias-sea.

Technically feasible solutions to challenges in preimplantation genetic testing for thalassemia: experiences of multiple centers between 2019 and 2022

Using affected embryos to establish linkage phase in preimplantation genetic testing for thalassemia

A Comprehensive Preimplantation Genetic Testing Approach for SEA-type Α-Thalassemia by Fluorescent Gap-Polymerase Chain Reaction Combined with Haplotype Analysis

Application of real‐time PCR–based multicolor melting curve with automatic analysis system in pregestational and prenatal thalassemia diagnoses

Embryo genome profiling by single-cell sequencing for preimplantation genetic diagnosis in a β-thalassemia family

Primer-introduced restriction analysis polymerase chain reaction method for non-invasive prenatal testing of β-thalassemia

A Pilot Study of Noninvasive Prenatal Diagnosis of Alpha- and Beta-Thalassemia with Target Capture Sequencing of Cell-Free Fetal DNA in Maternal Blood

Prenatal diagnosis of beta-thalassemia by reverse dot-blot hybridization in southern China

Simultaneous detection of genomic imbalance in patients receiving preimplantation genetic testing for monogenic diseases (PGT-M)

Appropriate whole genome amplification and pathogenic loci detection can improve the accuracy of preimplantation genetic diagnosis for deletional α-thalassemia

Integration of targeted sequencing and pseudo-tetraploid genotyping into clinically assisted decision support for β-thalassemia invasive prenatal diagnosis

Prenatal Diagnosis of Β-Thalassemia Using Multiplex Allele-Specific Amplification (MASPCR) in Chinese Families.

Invasive Molecular Prenatal Diagnosis of Alpha and Beta Thalassemia among Hakka Pregnant Women

Successful Preimplantation Genetic Diagnosis of Α-and Β-Double Thalassemia Combined with HLA Typing by Next Generation Sequencing

Rapid, Accurate Genotyping of Β‐thalassaemia Mutations Using a Novel Multiplex Primer Extension/denaturing High‐performance Liquid Chromatography Assay

Noninvasive prenatal testing of α-thalassemia and β-thalassemia through population-based parental haplotyping

Noninvasive prenatal testing for β-thalassemia by targeted nanopore sequencing combined with relative haplotype dosage (RHDO): a feasibility study